147 related articles for article (PubMed ID: 11559456)
21. The shifting nature of women's experiences and perceptions of ductal carcinoma in situ.
Kennedy F; Harcourt D; Rumsey N
J Adv Nurs; 2012 Apr; 68(4):856-67. PubMed ID: 21790736
[TBL] [Abstract][Full Text] [Related]
22. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
23. Prospective changes in quality of life after ductal carcinoma-in-situ: results from the Nurses' Health Study.
Nekhlyudov L; Kroenke CH; Jung I; Holmes MD; Colditz GA
J Clin Oncol; 2006 Jun; 24(18):2822-7. PubMed ID: 16782920
[TBL] [Abstract][Full Text] [Related]
24. Identifying opportunities to support patient-centred care for ductal carcinoma in situ: qualitative interviews with clinicians.
Nyhof BB; Wright FC; Look Hong NJ; Groot G; Helyer L; Meiers P; Quan ML; Baxter NN; Urquhart R; Warburton R; Gagliardi AR
BMC Cancer; 2020 Apr; 20(1):364. PubMed ID: 32354355
[TBL] [Abstract][Full Text] [Related]
25. Eliminating "ductal carcinoma in situ" and "lobular carcinoma in situ" (DCIS and LCIS) terminology in clinical breast practice: The cognitive psychology point of view.
Pravettoni G; Yoder WR; Riva S; Mazzocco K; Arnaboldi P; Galimberti V
Breast; 2016 Feb; 25():82-5. PubMed ID: 26614547
[TBL] [Abstract][Full Text] [Related]
26. Perceptions of contralateral breast cancer: an overestimation of risk.
Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
[TBL] [Abstract][Full Text] [Related]
27. The dilemma of DCIS.
Morrow M; O'Sullivan MJ
Breast; 2007 Dec; 16 Suppl 2():S59-62. PubMed ID: 17714949
[TBL] [Abstract][Full Text] [Related]
28. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
29. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
Westenberg AH; Rutgers EJ; Peterse JL; Hendriks JH; Beex LV; van Tienhoven G
Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2157-61. PubMed ID: 14626831
[TBL] [Abstract][Full Text] [Related]
30. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
31. Pain, sensory disturbances and psychological distress are common sequelae after treatment of ductal carcinoma in situ: a cross-sectional study.
Mertz BG; Duriaud HM; Kroman N; Andersen KG
Acta Oncol; 2017 May; 56(5):724-729. PubMed ID: 28447566
[TBL] [Abstract][Full Text] [Related]
32. In situ ductal carcinoma of the breast--analysis of clinical presentation and outcome in 156 consecutive cases.
Ciatto S; Grazzini G; Iossa A; Del Turco MR; Bravetti P; Cataliotti L; Cardona G; Bianchi S
Eur J Surg Oncol; 1990 Jun; 16(3):220-4. PubMed ID: 2161353
[TBL] [Abstract][Full Text] [Related]
33. Psychological morbidity in women diagnosed with ductal carcinoma in situ compared with women with early breast cancer receiving radiotherapy.
Pidduck W; Wan BA; Zhang L; Rakovitch E; Chow S; Chan S; Yee C; Drost L; Sousa P; Lewis D; Lam H; Leung E; Chow E
Support Care Cancer; 2020 May; 28(5):2247-2254. PubMed ID: 31451944
[TBL] [Abstract][Full Text] [Related]
34. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
[TBL] [Abstract][Full Text] [Related]
35. Recommendations to improve patient-centred care for ductal carcinoma in situ: Qualitative focus groups with women.
Nyhof BB; Wright FC; Look Hong NJ; Groot G; Helyer L; Meiers P; Quan ML; Baxter NN; Urquhart R; Warburton R; Gagliardi AR
Health Expect; 2020 Feb; 23(1):106-114. PubMed ID: 31532871
[TBL] [Abstract][Full Text] [Related]
36. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
Punglia RS; Schnitt SJ; Weeks JC
J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
[TBL] [Abstract][Full Text] [Related]
37. A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.
Liu Y; Pérez M; Schootman M; Aft RL; Gillanders WE; Ellis MJ; Jeffe DB
Breast Cancer Res Treat; 2010 Dec; 124(3):835-44. PubMed ID: 20446031
[TBL] [Abstract][Full Text] [Related]
38. Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.
Hart V; Sprague BL; Lakoski SG; Hampton JM; Newcomb PA; Gangnon RE; Trentham-Dietz A
J Clin Oncol; 2016 Apr; 34(12):1323-9. PubMed ID: 26884560
[TBL] [Abstract][Full Text] [Related]
39. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ
Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233
[TBL] [Abstract][Full Text] [Related]
40. Cosmesis outcomes for sector resection for ductal carcinoma in situ (DCIS).
Fosh B; Hainsworth A; Beumer J; Howes B; McLeay W; Eaton M
Ann Surg Oncol; 2014 Apr; 21(4):1271-5. PubMed ID: 24380921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
